LEVY Health and Everie Join Forces to Modernize Egg Donation Services
In a groundbreaking move aimed at transforming the egg donation landscape, LEVY Health has announced a strategic partnership with Everie, a leader in the known egg donation sector. This collaboration seeks to revolutionize the way aspiring parents connect with egg donors by combining cutting-edge technology with a person-centered approach. The egg donation process has traditionally faced various challenges, including high rejection rates and ethical dilemmas surrounding donor care. By merging LEVY Health's advanced clinical decision support software with Everie’s innovative egg bank services, the duo aims to address these challenges effectively.
One of the primary goals of this collaboration is to ensure that potential donors receive tailored assessments of their reproductive health. This is critical because existing strategies often overlook or exclude women with specific health conditions, such as polycystic ovary syndrome (PCOS). With LEVY Health's specialized screening algorithms, the partnership guarantees that these potential donors can receive a chance to contribute to the family-building journey.
Central to their strategy is the introduction of a state-of-the-art learning algorithm that monitors the screening processes right through to the donation phase and subsequent pregnancy outcomes. This data-driven approach allows for continuous refinement in the selection and testing of donors, as clinicians can become adept at identifying the best candidates quickly. The estimated timeline from the initial contact to actual donation has been dramatically reduced to a mere 2–3 months, promising accessibility and efficiency without compromising on medical standards.
Aisha Lewis, the President of Everie, emphasized the commitment to all stakeholders involved when she stated, "We are dedicated to supporting prospective parents, women who choose to be donors, and the individuals conceived through donation. By fusing LEVY Health’s technological expertise with our ethical framework, we are developing a process that is compassionate, clinically sound, and time-efficient."
Among the various features highlighted in this new initiative include comprehensive ovarian reserve testing. By employing age-appropriate and assay-specific insights into anti-Müllerian hormone (AMH) testing, LEVY Health helps ensure that no hopeful donor is unfairly excluded due to outdated clinical insights.
Additionally, the partnership aims to improve educational transparency surrounding reproductive health. Not only potential donors but also those who do not qualify will receive tailored information about their health, thus empowering them to make informed decisions while also considering ethical implications associated with egg donation.
Caroline Mitterdorfer, CEO and co-founder of LEVY Health, noted that, "It is entirely possible for cost efficiency and high moral standards in fertility care to coexist. By equipping potential donors with the essential tools and knowledge to enhance their health, we are setting a new benchmark in reproductive care."
Overall, this partnership marks a significant advancement in how egg donation procedures are conducted. By employing innovative technology and focusing on individualized care, LEVY Health and Everie are poised to cultivate a more inclusive and efficient environment for both donors and recipients alike. For more updates on this pioneering initiative in reproductive health, interested individuals can learn more by visiting the websites of LEVY Health and Everie.
One of the primary goals of this collaboration is to ensure that potential donors receive tailored assessments of their reproductive health. This is critical because existing strategies often overlook or exclude women with specific health conditions, such as polycystic ovary syndrome (PCOS). With LEVY Health's specialized screening algorithms, the partnership guarantees that these potential donors can receive a chance to contribute to the family-building journey.
Central to their strategy is the introduction of a state-of-the-art learning algorithm that monitors the screening processes right through to the donation phase and subsequent pregnancy outcomes. This data-driven approach allows for continuous refinement in the selection and testing of donors, as clinicians can become adept at identifying the best candidates quickly. The estimated timeline from the initial contact to actual donation has been dramatically reduced to a mere 2–3 months, promising accessibility and efficiency without compromising on medical standards.
Aisha Lewis, the President of Everie, emphasized the commitment to all stakeholders involved when she stated, "We are dedicated to supporting prospective parents, women who choose to be donors, and the individuals conceived through donation. By fusing LEVY Health’s technological expertise with our ethical framework, we are developing a process that is compassionate, clinically sound, and time-efficient."
Among the various features highlighted in this new initiative include comprehensive ovarian reserve testing. By employing age-appropriate and assay-specific insights into anti-Müllerian hormone (AMH) testing, LEVY Health helps ensure that no hopeful donor is unfairly excluded due to outdated clinical insights.
Additionally, the partnership aims to improve educational transparency surrounding reproductive health. Not only potential donors but also those who do not qualify will receive tailored information about their health, thus empowering them to make informed decisions while also considering ethical implications associated with egg donation.
Caroline Mitterdorfer, CEO and co-founder of LEVY Health, noted that, "It is entirely possible for cost efficiency and high moral standards in fertility care to coexist. By equipping potential donors with the essential tools and knowledge to enhance their health, we are setting a new benchmark in reproductive care."
Overall, this partnership marks a significant advancement in how egg donation procedures are conducted. By employing innovative technology and focusing on individualized care, LEVY Health and Everie are poised to cultivate a more inclusive and efficient environment for both donors and recipients alike. For more updates on this pioneering initiative in reproductive health, interested individuals can learn more by visiting the websites of LEVY Health and Everie.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.